Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacotherapy of the overactive bladder and advances in drug delivery.

× No keyword cloud information.

10 in total

Review 1. Botox in urology.

Authors: Ali Thwaini; Iqbal Shergill; Suresh Radhakrishnan; Frank Chinegwundoh; Hadeel Thwaini
Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2005-11-19

Review 2. Recent advances in intravesical drug/gene delivery.

Authors: Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal: Mol Pharm Date: 2006 Jul-Aug Impact factor: 4.939

Review 3. Improving the tolerability of anticholinergic agents in the treatment of overactive bladder.

Authors: Roger Dmochowski
Journal: Drug Saf Date: 2005 Impact factor: 5.606

Review 4. The puzzle of overactive bladder: controversies, inconsistencies, and insights.

Authors: Roger R Dmochowski
Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2006-06-27

5. Role of inflammation in bladder function and interstitial cystitis.

Authors: Sonal Grover; Abhishek Srivastava; Richard Lee; Ashutosh K Tewari; Alexis E Te
Journal: Ther Adv Urol Date: 2011-02

Review 6. Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.

Authors: Denis Getsios; Wissam El-Hadi; Ingrid Caro; J Jaime Caro
Journal: Pharmacoeconomics Date: 2005 Impact factor: 4.981

7. Transdermal oxybutynin: for overactive bladder.

Authors: Lynne M Bang; Stephanie E Easthope; Caroline M Perry
Journal: Drugs Aging Date: 2003 Impact factor: 3.923

8. Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women.

Authors: Raquel M Arruda; Rodrigo A Castro; Gabriela C Sousa; Marair G F Sartori; Edmund C Baracat; Manoel J B C Girão
Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2008-03-11

9. Oxybutynin extended release and tolterodine immediate release : a health economic comparison.

Authors: D Getsios; J J Caro; K J Ishak; W El-Hadi; K Payne; M O'connel; D Albrecht; W Feng; D Dubois
Journal: Clin Drug Investig Date: 2004 Impact factor: 2.859

Review 10. Social, economic, and health utility considerations in the treatment of overactive bladder.

Authors: Emilio Sacco; Daniele Tienforti; Alessandro D'Addessi; Francesco Pinto; Marco Racioppi; Angelo Totaro; Daniele D'Agostino; Francesco Marangi; Pierfrancesco Bassi
Journal: Open Access J Urol Date: 2010-02-11

10 in total